This case study discusses the causes, symptoms, and treatment options for asthma. It covers the various pathological conditions involved in asthma, the role of T helper cells in its development, and the medications used to treat it. The case study also includes a discussion on emergency care for acute severe asthma.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
Running head: CASE STUDY ON ASTHMA Case Study on Asthma Name of the Student Name of the University Author Note
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
1CASE STUDY ON ASTHMA Response to question 1. Asthma refers to a complex disorder that is characterized by the obstruction in the paroxysmal airwaysthat is the condition where the sensitivity of the airways is increased due to the inhalation ofthe eosinophilic inflammatory filtrate and spasmogens. In Asthma , various pathological condition is involved for example, bronchial inflammation long with the airway constriction , shortness of the breath , wheezing, coughing. Asthma mainly affects the trachea, bronchioles and bronchi.Edema, bronchospasm, excessive amount of mucous in the airway track and along with this damage of smooth muscle and epithelial cell damage can also leads to the condition of bronchoconstriction and ultimately results in Asthma. Bronchospasm refers to the sharp contraction of the bronchial smooth muscles and it results in constriction in the airways .In edema of the airways track there occurs microvascular leakage and it blocks the airway. In this condition, there occurs vasodilation of the airway capillaries and that causes more secretion of the mucous and causes blockage of the airways (Kudo, Ishigatsubo & Aoki, 2013). Asthma is also associated with the increasing level of IgE and also eosinophilic inflammation in the airways. After inhalation of various allergens like dust, pollens, fungi, animal dander, the T helper cells( Th2) are proliferatedand along with this Th2 cytokines, Interleukin ( IL)-5, IL-3 and IL-4 are also produced and released (Lambrecht & Hammad, 2015). The inflammation in the airways is the major reason of this disease. The inflammation is mainly induced by the chemical mediators released by those inflammatory cells.This causes inflammation of the airways and thickening of the airway wall. This thickening of the airways causes narrowing of the trachea and asthmaisdeveloped.InthiscasestudyofSmith,inx-rayitisseenthat,hehada hyperinflamated lungs and it ismainly due to the blockage of the airways. Smith had been diagnosed with asthma when he was just 2 years old and also he had very low respiratory rate
2CASE STUDY ON ASTHMA than a healthy individual. Hyperinflamated lungs are mainly seen in the patients of chronic ophthalmic pulmonary disease ( COPD). Smith had severe dyspnoea and he could not even speak a sentence in one breath. The breath shortness is due to his obstruction in the tracheal airway. The allergen is taken up by the dendritic cells and after processing they are presented to the T helper cells. The activation of allergen specific T helper cells plays a major role in developing Asthma. In recent times, it is seen that Th17 and Th9 are also responsible for occurrence of this disease (Übel et al., 2014). The Th17 cells is responsible for the production of IL-17A, IL-22 and IL-F. The released cytokines is responsible for the airway inflammation and IL-17A is directly associated with the increased contraction of the airway smooth muscle ( ASM) (Chesné et al., 2015). In this case it can be assumed that, patient Smith had developed his Asthma due to the constriction of the tracheal airways and the excessive mucous plugging is also another key reason for the development of Asthma as he had hyperinflamated lungs observed in thechestx-ray.Inthisexcessivemucous,themucousmainlycontainslymphocytes, inflammatory cells, cell debris of the necrotic pathway of epithelial cells and mucin. In the case of Smith the main reason behind the breath shortness is the limitation of airflow to lungs due to constriction in the airway due to increased contractility of the ASM. The contraction of the ASM is associated with the influx of calcium ions from extracellular to intracellular environment and ions are entering through a voltage-dependent calcium channel . This increased concentration of the Calcium ion in the intracellular environment will cause stimulation of the G-protein coupled receptor pathway and result in activation ofthe Phospholipase C ( PLC). Activated PLC then helps in production of IP3 and IP3 stimulates the release of Calcium ions from the sarcoplasmic reticulum (SR). Released calcium ions then activates MLC kinase ( MLC K) by forming calcium calmodulin complex. MLCK then phosphorylates the regulatory MLCs to phosphorylated MLCs.
3CASE STUDY ON ASTHMA Thisultimatelyresults inactivationof myosin-actincrossbridgesand smooth muscles contractions (Kudo, Ishigatsubo & Aoki, 2013). Response to question 2. In the case of Jackson smith it is seen that, he had a 90 % SpO2in the room air and that is lower than the normal level ( 94-100% SpO2). As he had acute severe asthma, he should be given emergency care so that, he can get relief from his condition as soon as possible. In this case, nurses should emergency care and that should help Smith to get relief. Firstly, nurses should try emergency medicinesthat can result relief in Asthma.In this case of Asthma management, nurses should can start the medication with the nebulized salbutamol that is a beta agonist drug(Patel et al., 2015). The inhalation of this drug should be done via face musk. Along with this, the drug also can be delivered with oxygen (Gotera et al., 2013) as Smith has severe problem in breathing. In this case, oxygen should be treated as a medicine for Smith also. In addition to this, inhalation of ipratropium bromide can be used as an add-on therapy forSmith (Nakawah, Hawkins & Barbandi, 2013). With consideration of Smith’s acute severe asthma, CorticosteroidscanbehelpfulforSmithasitdownregulatestheformationofthe proinflammatory cytokines and ultimately reduces inflammation of the airway (Barnes , 2013). In another strategy, nurses can use the nurses can measure the peak flow to measure the airflow of the lungs. It is mainly used to see the expiratory rate of the air flow and it is known as peak expiratory flow ( PEF). After monitoring the PEF they can decide that what amount of air pressure can be given to Smith in order to give him relief (Lalloo et al., 2013).
Paraphrase This Document
Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
4CASE STUDY ON ASTHMA Response to question 3. 3.a)Inthiscase,nebulizedsalbutamol,nebulizedipatropiumbromide(4/24)andIV Hydrocortisone 100mg (6/24) is used to treat Jackson. Nebulized salbutamol acts on beta-2 adrenoreceptors and covalently binds at the active site of the receptor. The conformational changes in the receptor will cause conversion of the ATP to c-AMP. This results in decreased concentration of intracellular Ca+2level. As a result, vasodilation occurs and air can travel to the alveoli. This will relief asthma as there is a vasoconstriction in the trachea (Cazzola et al., 2013). Nebulized ipratropium bromide works via the action of c-GMP on the intracellular calcium ions and this causes lowering of the smooth muscle’s contractility and reliefs the acute asthma. Ipratropium mainly blocks the muscarinic cholinergic receptor and it blocks the receptor without any specificity and that ultimately results in decrease in production of c-GMP (Meurs et al., 2013). Hydrocortisone mainly reduce the release of mucous by lowering the secretion of macrophages and secrtagogue. It ultimately causes reduction of inflammation, swelling and allow the patients of Asthma to get more relief as there is severe mucous secretion in the asthma and reduction of mucous secretion will help the patients (Lohia, Schlosser & Soler, 2013). 3. b) During the administration of salbutamol a nurse should observe that whether there is any anxiety, palpation muscular cramp or not. In severe condition myocardial ischemia, tachycardia may occur. In this condition, nurses should immediately stops the drug and take action according to the symptoms. Positive effect should also be noted in case of positive response. In case of hydrocortisone nurses should note if there is any symptoms of mood swing, weakness, acne upset stomach or not. In such condition, medicines should be changed.In case ofipratropium bromide , nurses should be watchful to note any kind symptoms like of nausea, dizziness or more difficulty in breathing in the patient.
5CASE STUDY ON ASTHMA Barnes,P.J.(2013).Theophylline.Americanjournalofrespiratoryandcriticalcare medicine,188(8), 901-906. Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013). β2-agonist therapy in lung disease.American journal of respiratory and critical care medicine,187(7), 690-696. Chesné, J., Braza, F., Chadeuf, G., Mahay, G., Cheminant, M. A., Loy, J., ... & Magnan, A. (2015). Prime role of IL-17A in neutrophilia and airway smooth muscle contraction in a housedustmite–inducedallergicasthmamodel.JournalofAllergyandClinical Immunology,135(6), 1643-1645. Gotera, C., Lobato, S. D., Pinto, T., & Winck, J. C. (2013). Clinical evidence on high flow oxygentherapyandactivehumidificationinadults.Revistaportuguesade pneumologia,19(5), 217-227. Kudo, M., Ishigatsubo, Y., & Aoki, I. (2013). Pathology of asthma.Frontiers in microbiology,4, 263. Lalloo, U. G., Ainslie, G. M., Abdool-Gaffar, M. S., Awotedu, A. A., Feldman, C., Greenblatt, M., ... & Otto, W. (2013). Guideline for the management of acute asthma in adults: 2013 update-Part 2: March 2013.SAMJ: South African Medical Journal,103(3), 189-200. Lambrecht,B.N.,&Hammad,H.(2015).Theimmunologyofasthma.Nature immunology,16(1), 45. Lohia, S., Schlosser, R. J., & Soler, Z. M. (2013). Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta‐analysis.Allergy,68(5), 569-579.
6CASE STUDY ON ASTHMA Meurs, H., Dekkers, B. G., Maarsingh, H., Halayko, A. J., Zaagsma, J., & Gosens, R. (2013). Muscarinicreceptorson airwaymesenchymalcells:novel findingsfor an ancient target.Pulmonary pharmacology & therapeutics,26(1), 145-155. Nakawah, M. O., Hawkins, C., & Barbandi, F. (2013). Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.The Journal of the American Board of Family Medicine,26(4), 470-477. Patel, M., Pilcher, J., Hancox, R. J., Sheahan, D., Pritchard, A., Braithwaite, I., ... & Beasley, R. (2015). The use of β 2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis.NPJ primary care respiratory medicine,25, 14099. References for Concept Map Bohadana, A., Izbicki, G., & Kraman, S. S. (2014). Fundamentals of lung auscultation.New England Journal of Medicine,370(8), 744-751. Castro, M., Zangrilli, J., Wechsler, M. E., Bateman, E. D., Brusselle, G. G., Bardin, P., ... & Korn, S. (2015). Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.The Lancet Respiratory Medicine,3(5), 355-366. Kudo, M., Ishigatsubo, Y., & Aoki, I. (2013). Pathology of asthma.Frontiers in microbiology,4, 263. Leigh, D., & Marley, E. (2016).Bronchial asthma: a genetic, population and psychiatric study. Elsevier.
Secure Best Marks with AI Grader
Need help grading? Try our AI Grader for instant feedback on your assignments.
7CASE STUDY ON ASTHMA Polosa, R., & Thomson, N. C. (2013). Smoking and asthma: dangerous liaisons.European respiratory journal,41(3), 716-726. Polosukhin, V. V., Richmond, B., Du, R. H., Ware, L. B., Lee, J. W., Miller, R. F., ... & Blackwell, T. S. (2017). D98 INSIGHTS INTO ENVIRONMENTAL EXPOSURES IN ASTHMA, COPD, AND CONSTRICTIVE BRONCHIOLITIS: Loss Of Multiciliated Epithelium And Impaired Mucosal Immunity In Lungs Of Soldiers With Constrictive Bronchiolitis.American Journal of Respiratory and Critical Care Medicine,195.
8CASE STUDY ON ASTHMA References Übel, C., Graser, A., Koch, S., Rieker, R. J., Lehr, H. A., Müller, M., & Finotto, S. (2014). Role of Tyk-2 in Th9 and Th17 cells in allergic asthma.Scientific reports,4, 5865.